Jigna Shah

Employment

• Nirma University of Science and Technology Institute of Pharmacy Professor
  2013 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (71)

• Vitamin D3 Attenuates Alzheimer’s Disease-Like Pathology via Remodeling Amyloid Protein Production and Clearance Pathway in Wistar Rats
  Neurochemical Research 2026 DOI: 10.1007/s11064-026-04721-x
  +Save
• Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Ind…
  ACS Pharmacology & Translational Science 2026 DOI: 10.1021/acsptsci.6c00045
  +Save
• Enhanced anti-cancer efficacy of Sorafenib and Pioglitazone via VEGF inhibition in DMBA-induced breast cancer model
  Toxicology Mechanisms and Methods 2025 DOI: 10.1080/15376516.2025.2537889
  +Save
• Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson’s Disease Mouse Models
  ACS Chemical Neuroscience 2025 DOI: 10.1021/acschemneuro.5c00112
  +Save
• Dual GLP-1 and GIP Agonist Tirzepatide Exerted Neuroprotective Action in a Parkinson’s Disease Rat Model
  ACS Chemical Neuroscience 2025 DOI: 10.1021/acschemneuro.4c00729
  +Save
• Antagonists of CD39 and CD73 potentiate doxycycline repositioning to induce a potent antitumor immune response
  Cellular Signalling 2025 DOI: 10.1016/j.cellsig.2024.111507
  +Save
• Quality by Design Driven Development of Lipid Nanoparticles for Cutaneous Targeting: A Preliminary Approach
  Research Square 2024 DOI: 10.21203/rs.3.rs-4327009/v1
  +Save
• Targeted Therapy for the Central Nervous System
  Targeted Therapy for the Central Nervous System: Formulation, Clinical Challenges, and Regulatory Strategies 2024 DOI: 10.1016/C2023-0-01145-1
  +Save
• SR-B1 receptor targeting in CNS disorders
  Targeted Therapy for the Central Nervous System: Formulation, Clinical Challenges, and Regulatory Strategies 2024 DOI: 10.1016/B978-0-443-23841-3.00010-8
  +Save
• Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach
  Drug Delivery and Translational Research 2024 DOI: 10.1007/s13346-024-01685-9
  +Save